Table 2. Comparison of suvorexant and zolpidem: likely benefits and risks.
possibly
suvorexant better |
possibly
zolpidem better |
not enough
data to guess |
|
---|---|---|---|
Immediate Benefits | |||
decreased sleep latency | X | ||
decreased wake after sleep onset | X | ||
increased total nightly sleep | X | ||
Immediate Risks | |||
daytime sleepiness and fatigue | X | ||
impaired driving | X | ||
impaired performance | X | ||
narcoleptiform symptoms | X | ||
amnesia, anxiety, hallucinations | X | ||
complex sleep behaviors | X | ||
depression and suicidal thoughts | X | ||
withdrawal insomnia | X | ||
infections | X | ||
respiratory depression | X | ||
falls | X | ||
addiction/abuse potential | X | ||
Long-term Risks & Benefits | |||
dementia | ? | ||
cancer | ? | ||
mortality vs survival | ? |
X Based on somewhat-parallel placebo-controlled-trials studies but no comparative-trials studies
? Based only on non-comparative epidemiology and scientific speculation